Nakamura, T., Kubota, T., Iwakaji, A., Imada, M., Kapás, M., & Morio, Y. (2016). Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment). Drug Des Devel Ther.
استشهاد بنمط شيكاغوNakamura, Tadakatsu, Tomoko Kubota, Atsushi Iwakaji, Masayoshi Imada, Margit Kapás, و Yasunori Morio. "Clinical Pharmacology Study of Cariprazine (MP-214) in Patients With Schizophrenia (12-week Treatment)." Drug Des Devel Ther 2016.
MLA استشهادNakamura, Tadakatsu, et al. "Clinical Pharmacology Study of Cariprazine (MP-214) in Patients With Schizophrenia (12-week Treatment)." Drug Des Devel Ther 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.